Plus: Costco shares fall after the retailer’s revenue misses Wall Street estimates. Bristol Myers-Squibb shares rise after the FDA approves its new treatment for schizophrenia patients. J.R. Whalen reports.  Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices